US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

DEFIANCE DAILY TARGET 2X LONG HIMS ETF

24.91

+0.23000.93%

Volume:164.73K

Turnover:4.09M

Market Cap:60.02M

PE:- -

High:25.84

Open:24.74

Low:24.15

Close:24.68

52wk High:391.58

52wk Low:12.38

Shares:2.41M

Float Shares:2.41M

Volume Ratio:0.59

T/O Rate:6.84%

Dividend:1.98

Dividend Rate:7.95%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

24H | Riot Platforms Jumps 25%; SMCI Climbs 1%; USA Rare Earth Tumbles 8%; Rocket Lab USA Drops 7%

Stocks to Watch: Hims & Hers, Rocket Lab, Plug Power, Babcock & Wilcox

Hims & Hers Says Testosterone Outpacing All Drugs Other than Weight-Loss

Hims & Hers Gets 17-Fold Explosion in Overseas Business

Hims & Hers Health Testing Peptide Ingredients Ahead of Expected FDA Decision on Allowing Compounding for the Drugs - Conf Call

THOMSON REUTERS

Hims & Hers Expects Gross Margins to Remain Below Historical Levels, Due to International, Weight-Loss Business Expansion - Conf Call

THOMSON REUTERS

Hims & Hers Exec Says AI Technology to Lower Prices for Weight-Loss Subscribers in 2026- Conf Call

THOMSON REUTERS

Hims & Hers Says Co in Process of Testing Bpc-157 Peptide- Conf Call

THOMSON REUTERS

Hims Stock Falls on Earnings. Why a Guidance Hike Isn't Enough.

Hims & Hers Able to Scale Peptide Offering if US Law Allows, CFO Says

Hims & Hers Health, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Hims & Hers Health: International Operations, Weight-Loss Products Produced Lower Profit Margins for Hims in Second Quarter, CFO Says

THOMSON REUTERS

Hims & Hers Health Confident it Can Rapidly Scale Peptide Offering if Current Regulation Allows, CFO Says

THOMSON REUTERS

Hims & Hers Health Boosts Revenue Target, Swings to 2Q Loss

Hims & Hers Shares Drop After Mixed Q2 Earnings — Details

Benzinga Earnings

Telehealth Platform Hims & Hers Swings to Q2 Net Loss as Margin Pressure Offsets Revenue Growth

Earnings Flash (HIMS) Hims & Hers Health Posts Q2 Loss $0.37, vs. FactSet Est of $0.05 Loss

MT Newswires Live

Hims & Hers Q2 FY26 Net Loss Widens to $86.3 Million; Revenue Rises 38% to $753.2 Million

Hims & Hers Health Inc: Making a Multi-Year Commitment to Invest in AI

THOMSON REUTERS

Hims & Hers Health Inc: Expect AI Investment to Pay for Itself Within 12 to 18 Months, Expect it to Make Offerings More Affordable for Customers

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/HIMZ/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"HIMZ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HIMZ\",,,,,undefined,":{"symbol":"HIMZ","market":"US","secType":"STK","nameCN":"DEFIANCE DAILY TARGET 2X LONG HIMS ETF","latestPrice":24.91,"timestamp":1789588799875,"preClose":24.68,"halted":0,"volume":164726,"delay":0,"changeRate":0.00931928687196112,"floatShares":2409608,"shares":2409608,"eps":0,"marketStatus":"Post-Mkt","change":0.23,"latestTime":"09-16 16:00:04 EDT","open":24.74,"high":25.8426,"low":24.145,"amount":4094038.067024,"amplitude":0.068784,"askPrice":25.07,"askSize":100,"bidPrice":24.9,"bidSize":100,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789603200000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":24.68,"sharesOutstanding":57385000,"nav":26.5,"aum":63059585.5,"dividendRate":0.079486,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":24.88,"preClose":24.68,"latestTime":"09:29 EDT","volume":885,"amount":21994.76694,"timestamp":1789565345679,"change":0.2,"changeRate":0.008104,"amplitude":0.026207},"volumeRatio":0.593692,"impliedVol":1.306,"impliedVolPercentile":0.1713},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HIMZ\",,,,,undefined,":{"symbol":"HIMZ","floatShares":2409608,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.593692,"shares":2409608,"dividePrice":1.98,"high":25.8426,"amplitude":0.068784,"preClose":24.68,"low":24.145,"week52Low":12.3816,"pbRate":"--","week52High":391.58,"institutionHeld":0,"latestPrice":24.91,"eps":0,"divideRate":0.079486,"volume":164726,"delay":0,"ttmEps":0,"open":24.74,"prevYearClose":81.06,"prevWeekClose":24.18,"prevMonthClose":28.37,"prevQuarterClose":48.7861,"fiveDayClose":25.12,"twentyDayClose":25.8,"sixtyDayClose":46.64},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HIMZ\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-19","symbol":"HIMZ","defaultRemindTime":1773927000000,"type":"split","dateTimestamp":1773892800000,"forFactor":14,"toFactor":1,"ratio":14}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HIMZ\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HIMZ\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HIMZ\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1103430375","title":"24H | Riot Platforms Jumps 25%; SMCI Climbs 1%; USA Rare Earth Tumbles 8%; Rocket Lab USA Drops 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1103430375","media":"US Overnight","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103430375?lang=en_us&edition=fundamental","pubTime":"2026-08-11 08:07","pubTimestamp":1786406846,"startTime":"0","endTime":"0","summary":"Dow Futures fell 0.10%, S&P 500 Futures fell 0.09%, Nasdaq Futures fell 0.15% as sentiment leaned cautious.Riot Platforms rose 24.48%. Shares advanced after it signed a 20-year, 191-megawatt AI data...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"64560525f7164c3f97e05313b2714ccc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4615","SMCI","BK4516","SMCL","GLAM","USAR","BK4168","HIYY","RKLZ","DAPP","IBLC","FSPC","HIMS","LFGY","HEAL","HIMZ","SMCY","HIMY","XME","LU1861215975.USD","BK4564","SMCX","BK4595","BKCH","BK4600","LU0053671581.USD","SMCZ","LU1861220033.SGD","RKLX","SMCC","RTYY","RIOX","DIPR","BLOX","SMYY","REXC","BK4585","BK4187","BK4023","THNR","BK4543","BK4170","BK4588","RIOT","USAX","USGG","BK4196","HMYY","RKLB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658395030","title":"Stocks to Watch: Hims & Hers, Rocket Lab, Plug Power, Babcock & Wilcox","url":"https://stock-news.laohu8.com/highlight/detail?id=2658395030","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658395030?lang=en_us&edition=fundamental","pubTime":"2026-08-11 07:13","pubTimestamp":1786403580,"startTime":"0","endTime":"0","summary":"Hims & Hers Health swung to a second-quarter loss, despite lifting its revenue outlook for the year. Shares fell 6.7% to $29.63 in after-hours trading on Monday.Rocket Lab narrowed its second-quarter loss as revenue grew, and said it would establish an entity in Germany. The stock fell 6.8% to $74.60 after the bell.Plug Power lifted its full-year revenue guidance after narrowing its second-quarter loss. Shares gained 7% to $2.26.Babcock & Wilcox Enterprises reported revenue ahead of analysts' expectations. Shares surged 41% to $12.48.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLAM","BK4588","HIMZ","LU2249611893.SGD","THNR","HIMY","LU2357305700.SGD","PLUG","LU1720051108.HKD","HMYY","BK4585","BK4615","LU0823414478.USD","HIMS","LU1548497426.USD","BK4541","RKLX","BWSN","BK4096","PLUL","FSPC","BK4187","DIPR","LU1720051017.SGD","BK4196","HIYY","BK4564","HEAL","RKLB","RKLZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658952087","title":"Hims & Hers Says Testosterone Outpacing All Drugs Other than Weight-Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2658952087","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658952087?lang=en_us&edition=fundamental","pubTime":"2026-08-11 05:52","pubTimestamp":1786398720,"startTime":"0","endTime":"0","summary":"1752 ET - Hims & Hers CEO Andrew Dudum says the demand for low-testosterone treatments has the category scaling faster than any other specialty outside of weight loss. Many men are experiencing low testosterone without knowing it, chalking their symptoms up to fatigue or aging, the CEO says in a call with analysts. The company has designed an experience, involving at-home blood collection and treatment that adapts over time, that is resonating with customers, Dudum says. The products' success just three quarters after launch gives management confidence in its ability to expand into injectable and oral TRT before the end of the year, according to Dudum.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMY","HIYY","HEAL","HMYY","THNR","HIMS","BK4196","GLAM","HIMZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658795241","title":"Hims & Hers Gets 17-Fold Explosion in Overseas Business","url":"https://stock-news.laohu8.com/highlight/detail?id=2658795241","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658795241?lang=en_us&edition=fundamental","pubTime":"2026-08-11 05:39","pubTimestamp":1786397940,"startTime":"0","endTime":"0","summary":"1738 ET [Dow Jones]--Hims & Hers said its international business had a 17-fold explosion in growth for 2Q. So-called \"rest of the world\" revenue came in at $131.4 million, compared with just $7.5 million in the same quarter a year ago. The overseas business now makes up a significant chunk of the company's overall revenue, stacking against $621.8 million in domestic revenue for 2Q. The company officially entered Canada in December and finalized the acquisition of Zava, a platform in Europe, last year. The company just closed its acquisition of Eucalyptus, a digital platform that will help it expand into Australia and Japan while growing its presence in the U.K., Germany and Canada.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HEAL","GLAM","HMYY","HIMZ","THNR","HIMY","BK4196","HIYY","HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658952876","title":"Hims & Hers Health Testing Peptide Ingredients Ahead of Expected FDA Decision on Allowing Compounding for the Drugs - Conf Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2658952876","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658952876?lang=en_us&edition=fundamental","pubTime":"2026-08-11 05:19","pubTimestamp":1786396790,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nFWN4471SF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HIMS","THNR","HMYY","BK4196","GLAM","HIMZ","HIMY","HEAL","HIYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658952197","title":"Hims & Hers Expects Gross Margins to Remain Below Historical Levels, Due to International, Weight-Loss Business Expansion - Conf Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2658952197","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658952197?lang=en_us&edition=fundamental","pubTime":"2026-08-11 05:19","pubTimestamp":1786396790,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nFWN4471SF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4196","HIMZ","HIYY","THNR","HIMY","HIMS","HEAL","HMYY","GLAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658488952","title":"Hims & Hers Exec Says AI Technology to Lower Prices for Weight-Loss Subscribers in 2026- Conf Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2658488952","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658488952?lang=en_us&edition=fundamental","pubTime":"2026-08-11 05:19","pubTimestamp":1786396790,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nFWN4471SF:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["THNR","HIMY","HEAL","HIYY","HIMZ","HIMS","HMYY","BK4196","GLAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658448952","title":"Hims & Hers Says Co in Process of Testing Bpc-157 Peptide- Conf Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2658448952","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658448952?lang=en_us&edition=fundamental","pubTime":"2026-08-11 05:19","pubTimestamp":1786396790,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nFWN4471SF:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["THNR","HEAL","HMYY","HIMZ","HIMS","GLAM","HIMY","HIYY","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658954013","title":"Hims Stock Falls on Earnings. Why a Guidance Hike Isn't Enough.","url":"https://stock-news.laohu8.com/highlight/detail?id=2658954013","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658954013?lang=en_us&edition=fundamental","pubTime":"2026-08-11 05:12","pubTimestamp":1786396320,"startTime":"0","endTime":"0","summary":"Hims & Hers Health hiked its full-year revenue guidance well above Wall Street targets, even as a wider-than-expected quarterly loss pushed shares lower in late trading Monday.The telehealth company f","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLAM","HIYY","HIMY","HIMZ","THNR","BK4196","HIMS","HMYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658954258","title":"Hims & Hers Able to Scale Peptide Offering if US Law Allows, CFO Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2658954258","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658954258?lang=en_us&edition=fundamental","pubTime":"2026-08-11 05:08","pubTimestamp":1786396110,"startTime":"0","endTime":"0","summary":"Hims & Hers able to scale peptide offering if US law allows, CFO saysNEW YORK, Aug 10 (Reuters)-Hims & Hers Health CFO Yemi Okupe said on Monday the telehealth company could rapidly sell peptide products at scale, if U.S. regulation allows.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nFWN4471UT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","HMYY","GLAM","HEAL","THNR","HIMS","HIMZ","HIYY","HIMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658095467","title":"Hims & Hers Health, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2658095467","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658095467?lang=en_us&edition=fundamental","pubTime":"2026-08-11 05:00","pubTimestamp":1786395648,"startTime":"0","endTime":"0","summary":"Hims & Hers Health, Inc. reports results for the quarter ended June 30 - Earnings SummaryHims & Hers Health, Inc.HIMS.Nreported a quarterly adjusted loss of 37 cents per share for the quarter ended Ju","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL8N4471Z2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HMYY","HIMY","BK4196","HIYY","GLAM","THNR","HIMS","HIMZ","HEAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658954585","title":"Hims & Hers Health: International Operations, Weight-Loss Products Produced Lower Profit Margins for Hims in Second Quarter, CFO Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2658954585","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658954585?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:41","pubTimestamp":1786394467,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nFWN4471UT:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HIMZ","BK4196","HMYY","HIMS","GLAM","HIMY","THNR","HIYY","HEAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658951208","title":"Hims & Hers Health Confident it Can Rapidly Scale Peptide Offering if Current Regulation Allows, CFO Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2658951208","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658951208?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:41","pubTimestamp":1786394467,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nFWN4471UT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["THNR","GLAM","HMYY","HIMZ","HEAL","HIMS","HIMY","HIYY","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658519329","title":"Hims & Hers Health Boosts Revenue Target, Swings to 2Q Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2658519329","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658519329?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:31","pubTimestamp":1786393860,"startTime":"0","endTime":"0","summary":"Hims & Hers Health raised its revenue projections for the year, though higher costs swung it to a loss in the second quarter.The telehealth platform said it now projects $3.1 billion to $3.3 billion i","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMY","HIMS","BK4196","GLAM","THNR","HMYY","HIMZ","HEAL","HIYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658285959","title":"Hims & Hers Shares Drop After Mixed Q2 Earnings — Details","url":"https://stock-news.laohu8.com/highlight/detail?id=2658285959","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658285959?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:17","pubTimestamp":1786393043,"startTime":"0","endTime":"0","summary":"Hims &amp; Hers posted Q2 results - here are the details you need to know.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/earnings/26/08/61092738/hims-hers-shares-drop-after-mixed-q2-earnings-details","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["THNR","GLAM","HMYY","HIMZ","HEAL","HIMS","HIMY","HIYY","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658959179","title":"Telehealth Platform Hims & Hers Swings to Q2 Net Loss as Margin Pressure Offsets Revenue Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2658959179","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658959179?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:15","pubTimestamp":1786392909,"startTime":"0","endTime":"0","summary":"Telehealth platform Hims & Hers swings to Q2 net loss as margin pressure offsets revenue growthOverviewUS health platform's Q2 revenue rose 38% yr/yr, beating analyst expectationsCompany posted Q2 net","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL1N4470VV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLAM","HIMZ","THNR","HIYY","HMYY","HIMS","BK4196","HIMY","HEAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658995931","title":"Earnings Flash (HIMS) Hims & Hers Health Posts Q2 Loss $0.37, vs. FactSet Est of $0.05 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2658995931","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658995931?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:09","pubTimestamp":1786392570,"startTime":"0","endTime":"0","summary":"Earnings Flash (HIMS) Hims & Hers Health Posts Q2 Loss $0.37, vs. FactSet Est of $0.05 Loss","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HIMZ","HMYY","GLAM","HIMS","HIMY","HEAL","HIYY","BK4196","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658995959","title":"Hims & Hers Q2 FY26 Net Loss Widens to $86.3 Million; Revenue Rises 38% to $753.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2658995959","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658995959?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:09","pubTimestamp":1786392559,"startTime":"0","endTime":"0","summary":"Hims & Hers Q2 FY26 net loss widens to $86.3 million; revenue rises 38% to $753.2 millionHims & Hers posted Q2 2026 revenue of USD 753.2 million, up 38% year-over-year; net results swung to a USD 86.3","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDL2PdtJ0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMS","HIYY","THNR","HEAL","GLAM","HIMZ","BK4196","HIMY","HMYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658959334","title":"Hims & Hers Health Inc: Making a Multi-Year Commitment to Invest in AI","url":"https://stock-news.laohu8.com/highlight/detail?id=2658959334","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658959334?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:08","pubTimestamp":1786392524,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nFWN4471PK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["THNR","BK4196","HMYY","HIMS","GLAM","HIMY","HIYY","HEAL","HIMZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658695934","title":"Hims & Hers Health Inc: Expect AI Investment to Pay for Itself Within 12 to 18 Months, Expect it to Make Offerings More Affordable for Customers","url":"https://stock-news.laohu8.com/highlight/detail?id=2658695934","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658695934?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:08","pubTimestamp":1786392524,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nFWN4471PK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HIMS","THNR","HMYY","BK4196","GLAM","HIMZ","HIMY","HEAL","HIYY"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}